Literature DB >> 26231992

Recent advances in genome editing and creation of genetically modified pigs.

James R Butler1, Joseph M Ladowski1, Gregory R Martens1, Matthew Tector1, A Joseph Tector2.   

Abstract

The field of xenotransplantation is benefiting greatly from recent advances in genetic engineering. The efficiency and pace with which new model animals are being created has dramatically sped progress towards clinical relevance. Endonuclease-driven genome editing now allows for the efficient generation of targeted genetic alterations. Herein we review the available methods of genetic engineering that have been successfully employed to create genetically modified pigs.
Copyright © 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endonuclease; Homologous recombination; Off-target; TALEN CRISPR/Cas9; Zinc finger nuclease

Mesh:

Year:  2015        PMID: 26231992     DOI: 10.1016/j.ijsu.2015.07.684

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  19 in total

1.  Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation.

Authors:  James R Butler; Gregory R Martens; Jose L Estrada; Luz M Reyes; Joseph M Ladowski; Cesare Galli; Andrea Perota; Conor M Cunningham; Matthew Tector; A Joseph Tector
Journal:  Transgenic Res       Date:  2016-04-21       Impact factor: 2.788

Review 2.  Genetically-engineered pigs as sources for clinical red blood cell transfusion: What pathobiological barriers need to be overcome?

Authors:  Benjamin Smood; Hidetaka Hara; Leah J Schoel; David K C Cooper
Journal:  Blood Rev       Date:  2019-01-28       Impact factor: 8.250

3.  Early barriers to neonatal porcine islet engraftment in a dual transplant model.

Authors:  K P Samy; R P Davis; Q Gao; B M Martin; M Song; J Cano; A B Farris; A McDonald; E K Gall; C R Dove; F V Leopardi; T How; K D Williams; G R Devi; B H Collins; A D Kirk
Journal:  Am J Transplant       Date:  2017-12-28       Impact factor: 8.086

4.  Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers.

Authors:  James Russell Butler; Leela L Paris; Ross L Blankenship; Richard A Sidner; Gregory R Martens; Joseph M Ladowski; Ping Li; Jose L Estrada; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

5.  Swine Leukocyte Antigen Class II Is a Xenoantigen.

Authors:  Joseph M Ladowski; Luz M Reyes; Gregory R Martens; James R Butler; Zheng-Yu Wang; Devin E Eckhoff; Matthew Tector; A Joseph Tector
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

6.  Prolonged Survival Following Pig-to-Primate Liver Xenotransplantation Utilizing Exogenous Coagulation Factors and Costimulation Blockade.

Authors:  J A Shah; M S Patel; N Elias; N Navarro-Alvarez; I Rosales; R A Wilkinson; N J Louras; M Hertl; J A Fishman; R B Colvin; A B Cosimi; J F Markmann; D H Sachs; P A Vagefi
Journal:  Am J Transplant       Date:  2017-06-06       Impact factor: 8.086

7.  Immune Responses of HLA Highly Sensitized and Nonsensitized Patients to Genetically Engineered Pig Cells.

Authors:  Zhongqiang Zhang; Hidetaka Hara; Cassandra Long; Hayato Iwase; Haizhi Qi; Camila Macedo; Massimo Mangiola; Adriana Zeevi; Mohamed Ezzelarab; David Ayares; David K C Cooper; Martin Wijkstrom
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

8.  Incidence of Neoplasia in Pigs and Its Relevance to Clinical Organ Xenotransplantation.

Authors:  Abhijit Jagdale; Hayato Iwase; Edwin C Klein; David Kc Cooper
Journal:  Comp Med       Date:  2019-03-25       Impact factor: 0.982

9.  Generation of insulin-deficient piglets by disrupting INS gene using CRISPR/Cas9 system.

Authors:  Bumrae Cho; Su Jin Kim; Eun-Jin Lee; Sun Mi Ahn; Jin Seok Lee; Dal-Young Ji; Kiho Lee; Jung-Taek Kang
Journal:  Transgenic Res       Date:  2018-04-24       Impact factor: 2.788

Review 10.  Stem cells and genome editing: approaches to tissue regeneration and regenerative medicine.

Authors:  Nozomu Takata; Mototsugu Eiraku
Journal:  J Hum Genet       Date:  2017-10-11       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.